Funding to stop Candida auris lacking

A high proportion of people who have been diagnosed with C. auris have died


Scientists who work in mycology — the study of fungi — say there is precious little money available to study Candida auris, according to an article on the STAT News website.

Candida auris is making news for its ability to resist multiple antifungal drugs and settle into hospital rooms so persistently it can take renovations to get rid of it.

The head of mycotic diseases at the Centers for Disease Control and Prevention (CDC) acknowledged his field hasn’t attracted the same kind of research dollars as other pathogens.

A high proportion of people who have been diagnosed with C. auris have died — the CDC estimates it’s between 30 percent and 60 percent.

Read the article.



July 16, 2019


Topic Area: Infection Control


Recent Posts

Disinfectant Contact Time: The Case for Biofilm Disruption

Contact time, while essential for compliance, does not reliably predict microbial reduction on actual healthcare surfaces.


Rethinking How Healthcare Facilities Fund Construction Projects

Rising costs and competing priorities are driving healthcare organizations to explore new financing arrangements and construction strategies.


Putting Trauma-Informed Design into Practice

Arnold's Place demonstrates how design choices can promote dignity and a sense of control for those experiencing homelessness.


Harris Health to Build New Freestanding Cancer Center

The center is planned to open in 2029, following the opening of the new O'Quinn Hospital along the North Loop at Lockwood.


Inland Empire Health Plan Opens Expanded San Bernardino Community Wellness Center

The new 33,000-square-foot center is nearly three times the size of the original location off Second Street.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.